V Wealth Advisors’s GSK GSK Stock Holding History

V Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-953	Closed	-$51K	–	410
2017 Q2	$51K	Buy	+953	New	+$50.8K	0.02%	315

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

V Wealth Advisors's GSK Position: Q3 2017 in Review

V Wealth Advisors sold out of GSK (GSK) in Q3 2017, closing a stake of 953 shares — an estimated $51K sold.

V Wealth Advisors first reported a position in GSK in Q2 2017 and held it in 1 quarter. The position peaked at $51K in Q2 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

V Wealth Advisors reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
V Wealth Advisors sold 953 GSK shares in Q3 2017, an estimated $51K.
V Wealth Advisors first reported a position in GSK in Q2 2017 and held it in 1 quarter.
V Wealth Advisors's GSK position peaked at $51K in Q2 2017.
741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on V Wealth Advisors's 13F filing for Q3 2017, filed 12 Oct 2017.